Lifeline Biotechnologies Inc (LLBO)

[SquirrelCage]

https://www.medtechintelligence.com/column/high-demand-for-breast-cancer-diagnosis-and-treatment-products-in-asia/

Article written September 21, 2018 and still states launch and expansion before "end of the year". Tic, toc indeed.

Other breast cancer diagnostics device manufacturers are also making inroads in Asian markets. Cyrcadia, Inc., based in Reno, Nevada, plans to launch sales of its wearable early breast wellness screening device, iTBra, through its Hong Kong subsidiary. The company plans a further expansion into China, Indonesia, Malaysia, the Philippines, Singapore and Thailand before the end of the year. According to Cyrcadia, the product is more than 80% accurate in detecting breast cancer for the densest breast tissue, compared to traditional mammography, which only has a 50% accuracy rate for that class of breast tissue.